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Skeletal muscle development (myogenesis) is a complex but precisely orchestrated process involving
spatiotemporal regulation of the proliferation, differentiation and fusion of myogenic progenitor cells
(myoblasts). Here we identify brain expressed x-linked gene 1 (Bex1) as a transient, developmentally
regulated gene involved in myoblast fusion. Bex1 expression is undetectable in adult muscles or in
quiescent muscle stem cells (satellite cells). During embryonic myogenesis, however, Bex1 is robustly
expressed by myogeninþ differentiating myoblasts, but not by Pax7þ proliferating myoblasts. Interest-
ingly, Bex1 is initially localized in the cytoplasm and then translocates into the nucleus. During adult
muscle regeneration, Bex1 is highly expressed in newly regenerated myoﬁbers and the expression is
rapidly downregulated during maturation. Consistently, in cultured myoblasts, Bex1 is not expressed at
the proliferation stage but transiently expressed upon induction of myogenic differentiation, following a
similar cytoplasm to nucleus translocation pattern as seen in vivo. Using gain- and loss-of-function
studies, we found that overexpression of Bex1 promotes the fusion of primary myoblasts without af-
fecting myogenic differentiation and myogenin expression. Conversely, Bex1 knockout myoblasts exhibit
obvious fusion defects, even though they express normal levels of myogenin and differentiate normally.
These results elucidate a novel role of Bex1 in myogenesis through regulating myoblast fusion.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Under normal situation, mammalian adult skeletal muscle is
relatively stable with minimal nuclei turnover, no more than 1–2%
per week (Schmalbruch and Lewis, 2000). However, skeletal muscle
is susceptible to a variety of injuries. Upon injury, skeletal muscle
has the outstanding capacity to initiate a rapid and extensive repair
process, namely muscle regeneration, to prevent further muscle loss
and maintain muscle mass. Of note, muscle stem cells, or satellite
cells, play an indispensable role in muscle regeneration (Sambasi-
van et al., 2011; von Maltzahn et al., 2013). In the early stage of
muscle regeneration, satellite cells are activated from quiescence
and proliferate as myoblasts to generate a sufﬁcient number of cells.
Subsequently, the proliferating myoblasts withdraw from the cell
cycle and fuse to the injury sites to repair muscle damage. As
muscle regeneration is a complex and highly orchestrated process,
unraveling the regulatory network governing muscle regeneration
has drawn intense research attention in regenerative biology.
Myoblast fusion is a crucial cellular process contributing to
muscle regeneration as well as muscle growth and development.Sciences, Purdue University,
e, IN 47907, United States.Myoblast fusion is characterized by cell attraction, migration, ad-
hesion, and alignment followed by the membrane rearrangement
and ﬁnally resolution (Doberstein et al., 1997). The fusion process
occurs through two phases. The ﬁrst stage leads to the formation
of nascent myotubes with few nuclei from myoblast–myoblast
fusion. The second stage results in the formation of large syncytia
with increased nuclear number and augmented myotube size from
myoblast fusion with nascent myotubes (Horsley and Pavlath,
2004). Much progress has been made in unraveling signaling
pathways underlying myoblast fusion in Drosophila, that occurs
between two genetically different cell subpopulations of founder
and fusion-competent myoblasts (Baylies et al., 1998). Of note, the
ELMO-Myoblast city-Rac pathway has been shown to play an es-
sential role in myoblast fusion (Duan et al., 2012; Geisbrecht et al.,
2008; Rushton et al., 1995). Intriguingly, this signaling pathway is
well conserved between Drosophila and vertebrates. It has been
reported that ELMO-DOCK1 (ortholog of Myoblast city)-Rac also
coordinately control the myoblast fusion in mice (Laurin et al.,
2008). Furthermore, the ELMO-DOCK1-Rac pathway is under the
control of brain-speciﬁc angiogenesis inhibitor (BAI) family mem-
bers, including BAI1 and BAI3, both of which have been corrobo-
rated to promote myoblast fusion (Hamoud et al., 2014; Ho-
chreiter-Hufford et al., 2013). Recently, a muscle-speciﬁc plasma
membrane protein, myomaker, has been identiﬁed to directly
participate in the myoblast fusion process (Millay et al., 2013).
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standing the fundamental process of myoblast fusion, the reg-
ulatory network controlling myoblast fusion in vertebrates re-
mains largely elusive.
Bex1 belongs to a small growing family including six members
with high homology in gene sequences and structures but distinct
in their expression patterns and subcellular localization (Alvarez
et al., 2005). Until now, the functions of Bex1 have been largely
unknown. Bex1 has been recently proposed to play key roles in the
formation of multiple signaling network hubs (Fernandez et al.,
2015). In particular, Bex1 has been identiﬁed as a regulator of
neuron regeneration, as Bex1 knockout mice are deﬁcient in axon
regeneration after sciatic-nerve injury (Khazaei et al., 2010). In
addition, Bex1 levels are cell-cycle dependent in PC12 neuronal
cells, with the lowest expression level in G1 phase and the highest
level in S phase. Moreover, down-regulation of Bex1 is necessary
for the cell cycle exit of neural progenitor cells, as overexpression
of Bex1 results in sustained proliferation even under growth-ar-
resting conditions. Further studies have conﬁrmed that Bex1 reg-
ulates cell cycle by interacting with p75 neurotrophin receptor
(p75NTR) to regulate the downstream signaling pathway (Vilar
et al., 2006). Besides its roles in the nervous system, Bex1 has been
identiﬁed as a candidate tumor suppressor gene because its in-
activation is associated with the development of various types of
tumors (Foltz et al., 2006; Karakoula et al., 2014; Lee et al., 2013).
The implication of Bex1 in muscle regeneration was discovered
by microarray analysis aimed to identify genes whose expression
is altered by cardiotoxin (CTX)-induced muscle injury, a well-es-
tablished model to study muscle regeneration (Goetsch et al.,
2003; Yan et al., 2003). A potential role of Bex1 in muscle re-
generation is further suggested by the observation Bex1 expres-
sion is dysregulated in the mdx mice (Turk et al., 2005), which
undergo progressive muscle degeneration and regeneration and
are widely used as a model to study Duchenne Muscular Dystro-
phy. Furthermore, Bex1 knockout mice displayed defective muscle
regeneration, manifested by prolonged proliferation and delayed
differentiation of myogenic cells (Koo et al., 2007). However, how
Bex1 regulates myoblast behavior and function is still unclear.
In this study, we ﬁrst examined the expression pattern of Bex1
during embryonic and adult myogenesis. We found that Bex1 is
transiently expressed by newly differentiated myoblasts and its
expression pattern undergoes dynamic cytoplasmic-nuclear traf-
ﬁcking. We further used gain- and loss-of-function studies to de-
termine how alternations of Bex1 levels affect myogenesis. We
found that Bex1 promotes myoblast–myotube fusion without af-
fecting myogenic differentiation per se. These data suggest that
Bex1 is temporally regulated during myogenesis to promote
myoblast fusion.2. Materials and methods
2.1. Animals
All procedures involving animal maintenance and experimental
use were performed based on the instructions established by
Purdue University's Animal Care and Use Committee. Bex1 KO
mice were provided by Prof. Frank L. Margolis (Koo et al., 2007).
Bex1 heterozygous mice were bred to generate Bex1 null and wild
type littermates used as controls in the experiments. The PCR
genotyping was done as previously described (Koo et al., 2007).
2.2. Muscle injury and regeneration
Muscle regeneration was induced by intramuscular injection
of Cardiotoxin (CTX; Sigma-Aldrich, St. Louis, MO). Mice wereanesthetized with a ketamine-xylazine cocktail, then 50 μl of
10 mM CTX was injected into the Tibialis Anterior (TA) muscle.
Muscles were harvested at day 5 and 14 post-injection for histo-
logical studies. Age- and gender-matched control mice were used
for each experiment.
2.3. Culture of skeletal muscle derived primary cells
Primary cells were isolated from limb skeletal muscles of
2-month old mice. Muscles were minced and digested with a
cocktail of type I collagenase and dispase B mixture (Roche Ap-
plied Science) and subsequently cultured in growth media (F-10
Ham's medium supplemented with 20% fetal bovine serum,
4 ng/mL basic ﬁbroblast growth factor, and 1% penicillin–strepto-
mycin) on collagen-coated dishes. Upon conﬂuence, cells were
differentiated in myogenic differentiation medium (DMEM sup-
plemented with 2% horse serum and 1% penicillin–streptomycin).
2.4. Cryosection
Fresh muscles were embedded in optimal cutting temperature
(OCT) compound (Sakura Finetek) and immediately frozen in dry
ice-cooled isopentane. Muscle blocks were cut at 10 μm with a
Leica CM 1850 cryostat instrument. The sections were placed on
Superfrost Plus glass slides (Electron Microscopy Sciences).
2.5. Immunostaining and image capture
Muscle tissue sections and cell cultures were ﬁrst ﬁxed in 4%
PFA solution and blocked in the blocking buffer containing PBS, 5%
goat serum, 2% bovine serum albumin, 0.2% Triton X-100 and 0.1%
sodium azide for 1 h. Next, the sections or cell cultures were in-
cubated with primary antibodies diluted in blocking buffer over-
night at 4 °C, then incubated with secondary antibodies and 4′,6-
diamidino-2-phenylindole (DAPI) diluted in PBS for 30 min at
room temperature, and ﬁnally mounted with Dako ﬂuorescent
mounting media (Glostrup, Denmark). Fluorescent pictures were
taken with a Coolsnap HQ CCD camera (Photometrics, USA) driven
by IP Lab software (Scanalytics, USA) in a Leica DMI 6000B ﬂuor-
escent microscope (Mannheim, Germany). As the analysis of the
immunoﬂuorescence was qualitative, identical image handling
and ﬂuorescence scoring criteria were applied in all the
experiments.
2.6. Recombinant adenovirus construction and infection
Recombinant adenoviruses expressing Bex1 were constructed
using the Adeasy system, including the adenoviral plasmid (pA-
dEasy-1) and the shuttle vector (pAdTrack-CMV), both of which
were kindly provided by Prof. Yongxu Wang. The pAdTrack-CMV
vector contains two separate CMV promoters driving the expres-
sions of GFP and Bex1 independently. The sequence of Bex1 was
PCR ampliﬁed and cloned into the pAdTrack-CMV vector. The re-
combination with the Adeasy1 plasmid and transfection to
HEK293 cells as well as ampliﬁcation of the recombinant adeno-
virus were performed as previously described (He et al., 1998). For
infection experiments, myoblasts were grown to 80% conﬂuence
and infected with virus for 48 h at 37 °C.
2.7. Quantitative real-time polymerase chain reaction (qPCR)
RNA was extracted and puriﬁed from muscles or cell cultures
using Trizol, followed by the digest with Turbo DNase (Ambion).
Random hexamer primers were used for the reverse transcription
from RNA to cDNA. qPCR was performed with a Light Cycler 480
machine (Roche). 18 s was used as housekeeping gene for
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plied to calculate the fold change.
2.8. Protein extraction and western blots analysis
Total protein was extracted from muscles or cells using RIPA
buffer containing 50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl
sulfate (SDS). Protein concentrations were measured by Pierce BCA
protein assay reagent (Pierce Biotechnology, Rockford, IL, USA).
Proteins were separated by SDS–polyacrylamide gel electrophor-
esis (SDS-PAGE), transferred to PVDF membranes (Millipore Corp.,
Billerica, MA), and probed with speciﬁc antibodies (Bex1, 1:5000
dilution, provided by Prof. Frank L. Margolis; Pax7, 1:10 culture
supernatant, DSHB, U Iowa; myogenin, 1:1000 dilution, Santa Cruz
Biotechnology; GAPDH, 1:1000 dilution, Santa Cruz Biotechnol-
ogy), then detected by chemiluminescence with FluorChem™ R
System (ProteinSimple, Santa Clara, CA, USA).
2.9. Statistical analysis
Data are displayed with mean7s.e.m. P-values were calculated
by two-tailed Student's t-test. P-values o0.05 were considered to
be statistically signiﬁcant.3. Results
3.1. Transient expression of Bex1 during muscle development and
regeneration
As the ﬁrst step to understand the function of Bex1 in muscle
development and regeneration, we sought to determine the ex-
pression of Bex1 using a previously validated polyclonal antibody
(Koo et al., 2005). As Pax7 and Myog have been widely used to
mark undifferentiated and differentiated myogenic progenitor
cells, respectively (Cheng et al., 1992; Relaix et al., 2005; Venuti
et al., 1995), we co-stained these proteins with Bex1 by im-
munohistochemistry to determine which cell population ex-
presses Bex1 at different stages of myogenesis in mice. At em-
bryonic day E10.5 when primary myogenesis begins (Biressi et al.,
2007), most progenitors in the somites (dermomyotome) were
Pax7þ , but none of them expressed Bex1 (Fig. 1A). However, Bex1
immunoﬂuorescence was co-localized to a subpopulation of
Myogþ cells (Fig. 1B). Inspection of intracellular localization in-
dicates that Bex1 is predominantly located in the cytoplasm at this
stage (Fig. 1B′). Interestingly, at stage E12.5 when the primary
myogenesis peaks (Biressi et al., 2007), Bex1 immunoﬂuorescence
signal is mostly localized in the nucleus (Fig. 1C). This nucleocy-
toplasmic dynamics is consistent with the previous study showing
both nucleus and cytoplasm locations in Bex1-transfected HEK 293
cells (Behrens et al., 2003).
In addition to the myotome, Bex1 immunoﬂuorescence was
also detectable in the neural tube and gut of E12.5 embryos
(Supplemental Fig. S1A). Furthermore, a small portion of Bex1þ
cells in the myotome were Myogenin (Fig. 1B), indicating a dis-
tinct identity. Interestingly, we detected the co-localization of Bex1
and PDGFRa in the myotome of E15.5 embryos (Supplemental Fig.
S1B), suggesting that Bex1 is expressed in the ﬁbroadipogenic
lineage cells. This is further conﬁrmed by Bex1 mRNA quantiﬁca-
tion showing 3 times more abundance in ﬁbroblasts compared to
myoblasts (Supplemental Fig. S1C). Bex1 signal was undetectable
in the muscle after E15.5 stage throughout embryonic and peri-
natal development (Supplemental Fig. S2). These results indicate
that Bex1 is only transiently expressed in differentiating or newly
differentiated muscle cells during embryonic myogenesis.We also examined the expression pattern of Bex1 during
postnatal muscle regeneration. In the absence of muscle injury,
Bex1 signal was undetectable in resting muscles (Fig. 2A, Day 0),
suggesting that Bex1 is not required for maintaining normal
muscle function. Upon CTX-induced muscle regeneration, Bex1
was highly induced in the cytoplasm of central-nucleated re-
generating myoﬁbers at Day 5 post-injury, but its expression was
again undetectable at Day 14 (Fig. 2A). Importantly, Bex1 was also
expressed in mononuclear myogenic cells at Day 5, indicated by
the co-localization of Bex1 and Myogenin (Fig. 2B). In contrast,
Bex1 was not detected in any Myogeninþ mononuclear cells at
Day 3 (Fig. 2C), suggesting that Bex1 is turned on after Myogenin
induction. This is in line with the expression pattern of Bex1
during embryonic muscle development. Consistent with this ob-
servation, Bex1 mRNA levels also exhibited a similar temporal
expression pattern that peaks at Day 5 post-CTX injury (Fig. 2D),
when myoblasts have been extensively expanded and myoblast
fusion peaks (Robertson et al., 1990). After this time point, Bex1
expression dropped rapidly and returned to an undetectable level
at Day 14 (Fig. 2D), when the muscle regeneration was largely
completed. These data demonstrate that Bex1 is transiently ex-
pressed in nascent myotubes or newly regenerated myoﬁbers
during skeletal muscle development and regeneration, and sug-
gest a role of Bex1 in myoblast fusion.
3.2. Bex1 is exclusively expressed in differentiated myoblasts during
myogenic differentiation
To further model the dynamics of Bex1 expression in myo-
genesis, we examined the expression pattern of Bex1 in satellite
cells during their activation, proliferation and differentiation in
vitro under culture conditions. Under growth conditions, Bex1 is
barely detectable in proliferating myoblasts (Fig. 3A, left). Within
24 h upon serum withdrawal induced differentiation, Bex1 is
highly upregulated in the cytoplasm of a subpopulation of myo-
blasts (Fig. 3A, middle). At 3 days after differentiation, Bex1 ex-
pression is mainly located in the nucleus of newly formed myo-
tubes (Fig. 3A, right). Thereafter, Bex1 expression gradually de-
clines (data not shown). Quantitative PCR results indicate that
Bex1 mRNA levels increased by nearly 10-fold within 24 h and by
over 40-fold within 3 days after induced differentiation (Fig. 3B).
The relative levels of Bex1 protein exhibited a similar trend of
increase to Bex1 mRNA during differentiation of primary myo-
blasts (Fig. 3C). These results conﬁrm that Bex1 expression is in-
duced at the early stages of myogenic differentiation.
In addition, we performed single myoﬁber culture experiments
to mimic satellite cell activation, proliferation and differentiation
in vivo. After 72 h in culture, satellite cells attached on their host
myoﬁbers typically form clusters of cells containing both pro-
liferating and differentiating cells that are distinguishable by
markers (Fig. 3D–F). Co-staining these clusters with Bex1 and Pax7
reveals that Bex1 was never expressed in undifferentiated Pax7þ
myoblasts (Fig. 3D). Similarly, Bex1 signal was never found in
proliferating myoblasts that were Ki67þ (Fig. 3E). However, Bex1
signal was readily detectable in both the cytoplasm and nucleus of
Myogþ differentiating cells (Fig. 3F). These data again support the
notion that Bex1 expression is absent in proliferating myoblasts
but rapidly induced in newly differentiated myoblasts.
3.3. Bex1 promotes myoblast–myotube fusion without affecting
differentiation
To directly investigate the role of Bex1 in myogenesis, we ﬁrst
performed gain-of-function studies on primary myoblasts through
adenovirus-mediated overexpression. This approach led to roughly a
30 times increase in the Bex1 mRNA level in proliferating myoblasts
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myoblasts, as the proportions of cells at G1, S, G2/M phase were
indistinguishable between control and overexpression myoblasts
(Supplemental Fig. S3A). After being induced to differentiate for
24 h, both GFP control and Bex1 overexpressing myoblasts started
to form myosin heavy chain (MHC)-expressing nascent myotubes
(Fig. 4B). However, the myotube size and differentiation index were
indistinguishable between the control and Bex1 overexpression
groups (Fig. 4B and C), suggesting that Bex1 does not affect the
differentiation of primary myoblasts. Interestingly, the fusion in-
dexes were also identical between the control and Bex1 over-
expression groups (Fig. 4D), indicating that Bex1 does not regulate
myoblast–myoblast fusion and the initial formation of myotubes.
Accompanying the ﬁrst stage of myoblast–myoblast fusion is
the second stage involving fusion of myoblasts to nascent myo-
tubes, leading to increases in myotube size (hypertrophy). We next
asked if Bex1 regulates myoblast–myotube fusion by examining
myotubes at 96 h after induced differentiation. Strikingly, after
differentiated for 96 h, Bex1 overexpression caused a dramatic
accumulation of nuclei in myotubes, leading to apparent myotubeE1
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Fig. 1. Expression pattern of Bex1 in muscle progenitors during embryonic developm
antibodies recognizing Bex1 together with Pax7 (A), or Bex1 and Myogenin (B) showing
boxed area in B. Nuclei were counterstained with DAPI (blue). (C) Representative images
and Bex1 (green), showing that Bex1 undergoes cytonucleotrafﬁcking from cytoplasm ahypertrophy (Fig. 5A). Using a quantitative measurement, we found
that the percentages of myotubes with 5 or more nuclei was sig-
niﬁcantly increased by Bex1 overexpression, with a concomitant re-
duction of small myotubes containing 2–4 nuclei/myotube (Fig. 5B).
The myotube hypertrophy was correlated to a higher level of Bex1
protein, but the levels of Myog or MHC protein were comparable be-
tween the control and Bex1 overexpression groups (Fig. 5C). We fur-
ther corroborated the results in C2C12 myoblasts using electroporation
mediated gene transfer, followed by 6 days of differentiation. Again,
Bex1 overexpression led to apparent hypertrophy of the myotubes
(Fig. 5D). The average number of myonuclei per myotubewas 4.7 in the
control cells, but this number increased to 9.4 in the Bex1 over-
expressing myotubes (Fig. 5E). Altogether, these data suggest that Bex1
promotes myoblast–myotube fusion without affecting myogenic dif-
ferentiation per se.
3.4. Bex1 knockout myoblasts are defective in myoblast–myotube
fusion in vitro
We also carried out loss-of-function studies to conﬁrm the role                 Merge
ent. (A and B) Cross sections of E10.5 embryos at the level of the somites, using
a concurrent expression of Bex1 and Myogenin. B′ shows an enlarged view of the
of myogenic cells in somites at E12.5, using antibodies recognizing Myogenin (red)
t E10.5 to nucleus at E12.5. Nuclei were counterstained with DAPI (blue).
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primary myoblasts isolated from littermate wildtype (WT) and
Bex1 knockout (KO) mice, which have been shown to have re-
generation defects (Khazaei et al., 2010; Koo, 2010; Koo et al.,
2007). The primary myoblasts from the Bex1 KO mice were normal
in terms of proliferative capacity, manifested by normal growth
rate and comparable abundance of Ki67þ cells between WT and
KO myoblasts (Supplemental Fig. S3B). After being differentiated
for 24 h, the Bex1 KO myoblasts formed nascent myotubes nor-
mally, indistinguishable from WT control in terms of nuclei
number per myotube and myotube size (data not shown).0 day
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per myotube (Fig. 6A). On average, the percentage of large myo-
tubes containing 5 or more nuclei was signiﬁcantly lower in the
Bex1 KO (24%) than that of the WT (43%), and the percentage of
small myotubes containing 2–4 nuclei/myotube was signiﬁcantly
higher in the KO group (Fig. 6B). The reduced myotube size in the
KO cultures was not associated with reductions in the levels of
Myog or MHC proteins (Fig. 6C), suggesting that Bex1 KO does not
affect myogenic differentiation per se. Collectively, these gain- and5 day 14 day
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motes myoblast–myotube fusion and myotube hypertrophy.4. Discussion
In this study, we show that Bex1 is expressed following myo-
genic differentiation during embryonic muscle development as
well as being transiently induced during muscle regeneration. We
also ﬁnd that Bex1 is speciﬁcally expressed in differentiated
myocytes in vitro. Of note, Bex1 undergoes translocation from the
cytoplasm to the nucleus as differentiation proceeds. We used
gain- and loss-of-function studies to demonstrate that Bex1
functions to promote myoblast–myotube fusion without affect-
ing myogenic differentiation. These results collectively elucidate a
transient role of Bex1 in embryonic and postnatal myogenesis.
Previous studies suggested that Bex1 plays roles in myoblast
cell cycle withdrawal as knockout myoblasts had prolonged pro-
liferation and delayed differentiation compared to WT mice during
muscle regeneration (Koo et al., 2007). The conclusion was drawn
based on analyzing the proliferation marker PCNA and cyclin-de-
pendent kinase inhibitors (CDKIs) in whole muscle tissues, but not
speciﬁcally in myoblasts. Evidently, regenerating muscles contain
various types of cells including inﬂammatory cells, endothelial
cells and ﬁbroblasts (ﬁbroadipogenic cells), whose proliferation
could also be affected by Bex1. To test whether Bex1 regulates cell
cycle withdrawal in myoblasts, we carried out cell cycle analysis
using ﬂow cytometry after adenovirus mediated Bex1 over-ex-
pression. However, Bex1 over-expression did not shift cell cycle0
10
20
30
40
50
%
nu
cl
ei
 in
 m
yo
si
n
GFP Bex1
Differentiation index
MHGFP
*
B
ex
1 
m
R
N
A
 le
ve
l
0
20
40
60
G
FP
B
ex
1
+ 
ce
lls
Fig. 4. Bex1 overexpression does not affect myoblast–myoblast fusion. (A) Quantitative
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*Po0.05 compared with GFP-infected cells.distribution (Supplemental Fig. S3A), suggesting that Bex1 does
not regulate cell cycle in myoblasts. We also conducted Ki67 im-
munostaining on Bex1 KO and WT myoblasts and calculated the
percentage of Ki67 positive cells. We did not detect any differences
in the abundance of Ki67 positive cells between WT and KO
myoblasts (Supplemental Fig. S3B). Moreover, we showed that
Bex1 did not regulate myogenic differentiation per se (Fig. 4).
Collectively, these data demonstrated that Bex1 did not regulate
the cell transition from proliferation and differentiation.
It has been well documented that Bex1 is abundantly expressed in
neurons with a dynamic nucleocytoplasmic distribution pattern. This
nucleocytoplasmic trafﬁcking was associated with neuron growth
factor (NGF) induced p75NTR signaling pathway (Lee et al., 2013).
Here, we also observed the nucleocytoplasmic distribution pattern in
myogenic cells. Bex1 was initially diffusely expressed in the cytoplasm
but then translocated to the nucleus at later stages of differentiation.
This nucleocytoplasmic trafﬁcking may also be related to the p75NTR
signaling pathway as p75NTR has been reported to have high ex-
pression levels in developing rat myoblasts as well as in rat and
chicken muscles (Ernfors et al., 1988; Lomen-Hoerth and Shooter,
1995; Raivich et al., 1985, 1987; Schecterson and Bothwell, 1992; Ya-
mamoto et al., 1996). Another possible signaling pathway is the Ca2þ
dependent signaling pathway, which plays indispensable roles in
myogenic differentiation. It has been reported that Bex1 can directly
interact with Calmodulin (CaM) (Koo et al., 2007), the ubiquitous
Ca2þ-binding protein, which mediates the uptake of various nuclear
proteins (Sweitzer and Hanover, 1996), such as NFAT isoforms. It
would be interesting to investigate in future studies the underlying
mechanisms and functional signiﬁcance of the nucleocytoplasmic
trafﬁcking of Bex1 during myogenesis.0
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liferation, differentiation and fusion of myoblasts into multi-
nucleated myoﬁbers. The spatiotemporal expression pattern of
Bex1 suggests that Bex1 plays a critical role during myogenic dif-
ferentiation. Here, we veriﬁed that Bex1 could positively regulate
myoblast fusion with myotubes. Interestingly, the primary fusion
was not affected by either Bex1 overexpression or knockout. How
Bex1 regulates myoblast–myotube fusion remains largely un-
known. Recently, it was reported that apoptotic cells can induce
the ELMO/DOCK1/Rac pathway through the cell surface protein0
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Besides, Bex3 has been identiﬁed to interact with p75NTR to
mediate the apoptosis pathway (Mukai et al., 2000). Given that
Bex1 and Bex3 both share similar sequences required for p75NTR
binding, it is plausible to hypothesize that Bex1 could promote
apoptosis through interaction with p75NTR, which consequently
initiates the ELMO/DOCK1/Rac signaling pathway and mediates
the fusion. Although Bex1 knockout myoblasts are defective in
myoblast–myotube fusion in vitro, the mutant mice have normal
muscle development and regeneration. This might be attributable5
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C. Jiang et al. / Developmental Biology 409 (2016) 16–2524to the compensatory effect of other Bex family members in the
absence of Bex1. Alternatively, if Bex1 regulates fusion through
apoptosis, massive muscle degeneration could overwhelm the ef-
fect of Bex1 on cell apoptosis, and mask any defects of myoblast
fusion in the Bex1 KO mice. Generating Bex1 transgenic mice to
overexpress Bex1 or Bex1/Bex3 compound KO mice may provide
additional clues to the in vivo role of Bex1 in muscle development
and regeneration. Nevertheless, our study contributes to our un-
derstanding the cellular and molecular mechanism of myogenesis,
especially the molecular regulation of myoblast fusion. These data
may have implications in the development of therapeutic strate-
gies to treat muscle diseases primarily caused by fusion defects.Acknowledgments
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